Susquehanna Fundamental Investments’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-29,316
Closed -$44.9K 715
2025
Q1
$44.9K Buy
+29,316
New +$44.9K ﹤0.01% 1041